The tumor suppressor miR-124 inhibits cell proliferation and invasion by targeting B7-H3 in osteosarcoma-Reference-Cited by-同舟云学术

The tumor suppressor miR-124 inhibits cell proliferation and invasion by targeting B7-H3 in osteosarcoma

Published:2016-09-20 Issue:11 Volume:37 Page:14939-14947
ISSN:1010-4283
Container-title:Tumor Biology
language:en
Short-container-title:Tumor Biol.

Author:

Wang Ling,Kang Fu-biao,Sun Nan,Wang Juan,Chen Wei,Li Dong,Shan Bao-en

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13277-016-5386-2.pdf

Reference45 articles.

1. Benjamin RS. Osteosarcoma: better treatment through better trial design. The Lancet Oncology. 2015;16(1):12–3.

2. Berner K, Johannesen TB, Bruland OS. Clinical epidemiology of low-grade and dedifferentiated osteosarcoma in Norway during 1975 and 2009. Sarcoma. 2015;2015:917679.

3. Reed DE, Shokat KM. Targeting osteosarcoma. Proc Natl Acad Sci U S A. 2014;111(51):18100–1.

4. Bagcchi S. Osteosarcoma survivors’ risk of second cancer. The Lancet Oncology. 2014;15(10):e425.

5. Atkins MB, Larkin J. Immunotherapy combined or sequenced with targeted therapy in the treatment of solid tumors: current perspectives. J Natl Cancer Inst. 2016;108(6).

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A potential function for MicroRNA-124 in normal and pathological bone conditions;Non-coding RNA Research;2024-09

2. B7 homolog 3 in pancreatic cancer;World Journal of Gastroenterology;2024-08-21

3. Targeting pediatric solid tumors in the new era of RNA therapeutics;Critical Reviews in Oncology/Hematology;2024-08

4. Overexpression of miR-506-3p reversed doxorubicin resistance in drug-resistant osteosarcoma cells;Frontiers in Pharmacology;2024-02-14

5. N6-methyladenosine modification of B7-H3 mRNA promotes the development and progression of colorectal cancer;iScience;2024-02